TABLE 3.
2022 Price Benchmarks for a 30-Day Equivalent Supply for IPAY 2027 Selected Drugs
| Brand name | Generic name | List price | Part D net price | Estimated rebate (%) | Big Four/FSS price | Non-FAMP | Price based on the minimum statutory discount | MFP ceiling |
|---|---|---|---|---|---|---|---|---|
| Products whose ceiling may be defined by the minimum discount | ||||||||
| Xtandi | Enzalutamide | $12,339 | $9,470 | 23 | $7,909 | $9,533 | $7,150 | $7,150 |
| Pomalyst | Pomalidomide | $20,409 | N/A | N/A | $13,536 | $17,449 | $13,086 | $13,086 |
| Ibrance | Palbociclib | $14,426 | $12,130 | 16 | $10,193 | $13,055 | $9,791 | $9,791 |
| Calquence | Acalabrutinib | $13,990 | $13,431 | 4 | $10,323 | $12,642 | $9,481 | $9,481 |
| Austedo/Austedo XR | Deutetra-benazine | $6,198 | $4,812 | 22 | $4,511 | $5,382 | $4,037 | $4,037 |
| Vraylar | Cariprazine | $1,323 | $994 | 25 | $940 | $1,232 | $924 | $924 |
| Ofev | Nintedanib-esylate | $12,081 | $10,643 | 12 | $6,609 | $12,142 | $9,107 | $9,107 |
| Xifaxan | Rifaximin | $2,558 | $2,186 | 15 | $1,711 | $2,417 | $967a | $967 |
| Products whose ceiling may be defined by the estimated Part D net price | ||||||||
| Trelegy Ellipta | Fluticasone/Umeclidinium/Vilanterol | $642 | $305 | 53 | $438 | $617 | $463 | $305 |
| Breo Ellipta | Fluticasone/Vilanterol | $395 | $158 | 60 | $271 | $374 | $281 | $158 |
| Otezla | Apremilast | $4,193 | $2,223 | 47 | $2,620 | $3,842 | $2,881 | $2,223 |
| Linzess | Linaclotide | $508 | $244 | 52 | $344 | $475 | $357 | $244 |
| Ozempic/Wegovy/Rybelsus | Semaglutide | $1,017 | $428 | 58 | $626 | $880 | $660 | $428 |
| Janumet/Janumet XR | Sitagliptin/Metformin | $503 | $141 | 72 | $361 | $421 | $168a | $141 |
| Tradjenta | Linagliptin | $461 | $194 | 58 | $304 | $420 | $315 | $194 |
a
Denotes drugs where the minimum statutory discount is 40% of the non-FAMP. All other drugs have a minimum statutory discount set by 75% of the non-FAMP.
FSS = Federal Supply Schedule; MFP = maximum fair price; N/A = not applicable; non-FAMP = non–federal average manufacturer price; XR = extended-release.